News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

BioSpace News - All
The FDA Calls Pfizer (PFE)’s Next-Generation Lung Cancer Drug a Breakthrough 4/27/2017
Biogen (BIIB)'s Ex-CEO George Scangos Left a Very Wealthy Man 4/27/2017
This Is By Far the #1 Highest Paying Non-Executive Biotech Job in the U.S. 4/27/2017
AstraZeneca PLC (AZN) Dumps Two Drugs From Pipeline, Causing an Ex-Partner's Stock to Tank Some More 4/27/2017
The Biotech Job Title You've Probably Never Heard Of 4/27/2017
Another Biotech is Born as Bay Area's BridgeBio Pharma Launches Eidos Therapeutics With $27 Million 4/27/2017
Genentech (RHHBY) Quietly Shelves Phase II Cancer Contender 4/27/2017
Massachusetts' Avedro Banks $42 Million, Opens New Facility and Will Continue to Expand Its Team 4/27/2017
Top 10 R&D Scientist Skills in Demand 4/27/2017
Mark Your Calendars: 4 Biotechs Facing FDA Decision Dates in May 4/27/2017
9 Top Biotechs That Have Stashed Away a $133 Billion M&A Cashpile Overseas 4/27/2017
And So It Begins: Covance (LH) Cuts 100+ Employees in Shut Down 4/26/2017
AstraZeneca PLC (AZN)'s Cambridge Headcount Hits 2,000 as Its New HQ Hit Budget Woes 4/26/2017
Some Predict Biogen (BIIB)’s Alzheimer’s Drug Will Fail 4/26/2017
Dropping Revenue: Expect More Cuts and Closures as LabCorp (LH) Aligns Covance (LH) Biz 4/26/2017
Why High-Flying M&A Target Tesaro (TSRO) Recently Lost More Than a Quarter of Its Value 4/26/2017
Regeneron (REGN)'s Top Execs Get a Huge Pay Cut in 2016 But It's Still More Than Most of Us Have Ever Dreamed of 4/26/2017
AstraZeneca PLC (AZN)'s Lung Cancer Trial Gets Delayed 4/26/2017
Why This SoCal Pharma Could Be Your Best Bet on Alzheimer's 4/26/2017
Beleaguered Bay Area Pharma OncoMed (OMED) Lays Off Half Its Workforce 4/26/2017
Why Trump's Executive Order Could Rekindle M&A Feelings for Allergan (AGN), Pfizer (PFE) 4/26/2017
Gilead (GILD)'s $600 Million NASH Deal Finally Bears Fruit 4/26/2017
Embattled Marathon Pharma May Shutter Operations by May 1 4/26/2017
Rumor Mill: Johnson & Johnson (JNJ), Novartis AG (NVS) and Takeda (TKPYY) are All Making Googly Eyes at This Brazilian Drugmaker 4/26/2017
Fasten Your Seatbelt: Biogen (BIIB) Preps for a Deal-Making Bonanza 4/26/2017
Texas-based ePatientFinder CEO Looks to Revolutionize Clinical Trial Recruitment 4/25/2017
Now Theranos is Accused of Running Fake Tests and Setting Up Secret Company 4/25/2017
Germany's Fresenius Kabi AG Slams Down $4.3 Billion for Akorn (AKN) in U.S. Expansion 4/25/2017
Ophthotech (OPHT) Co-Founder and CEO to Step Down, CFO Named New Leader 4/25/2017
How This Iowa Biotech Could be a Perfect Match for M&A Hungry Gilead (GILD) 4/25/2017
Trump Invites Top Biotech Execs and Researchers for Meeting at the White House Next Month 4/25/2017
Elon Musk Outlines Plans for Bay Area Brain Implants Startup Neuralink 4/24/2017
Unstoppable Celgene (CELG) to Take Over Amgen (AMGN)'s Former Space in Cambridge 4/24/2017
Why 90% of This $26 Billion Biotech's Sales Could be At Risk Within the Next 2 Years 4/24/2017
Turing CEO and Shkreli Associate Exits Top Post, CSO Takes Over 4/24/2017
2 Biotech Players to Keep Your Eye On 4/24/2017
Immune Pharma CEO Steps Down to Lead R&D in Restructuring, May Spin Off Oncology Unit 4/24/2017
Former Pfizer (PFE) Cancer Scientist Gets All 5 Papers Retracted 4/24/2017
Novartis AG (NVS) Hires Bank of America (BAC) to Officially Review Alcon (ACL) Options 4/24/2017
Up to 4,100 Children Victims of Sanofi (SNY)'s Epilepsy Drug, Says French Regulator 4/21/2017
Bay Area Startup Atomwise Offers a Compelling Deal to Scientists Hunting for New Drugs 4/21/2017
No Doubt: This is the Top Gene-Sequencing Stock to Buy This Year 4/21/2017
Investors Accuse Theranos of Threatening to File for Bankruptcy If They Didn't Give Up Their Right to Sue 4/21/2017
Facebook Gives Rare Peek Into Secretive Brain-Powered Tech Unit 4/21/2017
3 Intriguing Small-Cap Biotechs to Put on Your Watchlist 4/21/2017
Editas Medicine (EDIT), Veritas Genetics Co-Founder and Biotech Phenom George Church Makes Time's 100 'Most Influential' List 4/21/2017
Bay Area's Atara Biotherapeutics (ATRA) Leases Huge Space in SoCal 4/20/2017
AbbVie (ABBV)'s PARP Inhibitor Fails to Deliver in Two Late-Stage Studies 4/20/2017
Novartis AG (NVS) Remains Hush-Hush About CAR-T Trial But the FDA is Impressed and Thinks It's a Breakthrough 4/20/2017
Juno (JUNO) Taps Ex-Genentech (RHHBY) Scientist to Head Up R&D at New Bay Area Office 4/20/2017
A Revealing Conversation With Booming Bay Area Biotech Relypsa (RLYP)’s President Scott Garland 4/20/2017
Exec Reveals Sanofi (SNY) is Hunting for M&As to Boost Diabetes Biz 4/20/2017
Johnson & Johnson (JNJ) Hosts 'Shark-Tank'-Like Competition and Crowned This Biotech Startup as Its Winner 4/20/2017
Tension Rises Between Vertex (VRTX) and Its Religious Investors Over Lobbying Disclosures 4/20/2017
FDA's Shorten Review Time is a Bad Sign for Puma Biotech (PBYI)'s Controversial Cancer Drug 4/20/2017
It's Officially the End of the Road for Massachusetts Biotech Nuclea Biotechnologies 4/20/2017
How Pfizer (PFE) Made Most of Its $52.8 Billion Last Year 4/20/2017
Why Former Medivation (MDVN) CEO and a Once-Failed Alzheimer's Drug Could be a Recipe for Disaster for Axovant (AXON) 4/20/2017
Where Billionaire-Led Intrexon (XON) Could Be in 10 Years 4/20/2017
Tech Giant Apple (AAPL) Hires Secret Team of Biomedical Engineers for Treating Diabetes 4/19/2017
Antibiotics Maker Steri-Pharma Wants to Create 72 New Jobs in New York 4/19/2017
How Biogen (BIIB) Lost Its Chance to Be the Hunter and Became the Hunted in Just a Few Months 4/19/2017
Actis Portfolio Company MediS Group Announces The Acquisition Of Winthrop Pharma Senegal From Sanofi (SNY) 4/19/2017
Ex-Dendreon (DNDN) CEO Returns to Biotech, Throws a Lifeline to Struggling Nivalis (NVLS) 4/19/2017
Cancer Biotech G1 Therapeutics Files for $115 Million IPO 4/19/2017
FDA Just Rejected Eli Lilly (LLY), Incyte (INCY)'s Rheumatoid Arthritis Drug Baricitinib 4/18/2017
This Year’s Superbug Norovirus Sickens Hundreds of Millions, Prompting Urgent Race for Vaccine 4/18/2017
Getting Off Easy? Embattled Theranos Could Have a Lab Again in 2019 4/18/2017
Hanmi Pharma (128940.KS) Charged for Failure to Report Patient Death in Olmutinib Study 4/18/2017
When It Rains, It Pours: Bay Area's OncoMed (OMED) Tanks Again as Lung Cancer Med Fails Phase II, Discontinues Phase I Study 4/18/2017
Perrigo (PRGO) Shakes Up Exec Roster and Board, Hands Out a Fistful of Pink Slips 4/18/2017
Pharma Giant Merck Sharp & Dohme (MRK) Could Bring 600 New Jobs to Austin 4/18/2017
New Biotech Incubator Emerges in Washington, Aims to Create Jobs and Hub Outside of Seattle 4/18/2017
You'll Want to Own This Biotech Stock in the Next Market Crash 4/17/2017
From Biohacker to Organ Farmer, You Won’t Believe These Amazing 8 Biotech Jobs of the Future! 4/17/2017
Chiltern International Ltd. Explores Sale Valued at $1.3 Billion 4/17/2017
Genentech (RHHBY) Shows Off Late-Stage Hemophilia A Data 4/17/2017
Drug Giant Aspen Pharmacare Plotted to Destroy Cancer Medicine to Jack Up Prices 4/17/2017
Bristol-Myers Squibb (BMY) Inks Two Separate Pacts With Biogen (BIIB) and Roche (RHHBY) For a Total of Up to $1.1B 4/14/2017
Boston's SV Life Sciences Unveils Name Change, Debuts $400M Fund for Biotech 4/14/2017
Top 10 Best Innovative Pharma Companies to Work For 4/14/2017
Abbott (ABT) Seals Alere (ALR) Deal at Lower Price, Ending Legal Battle 4/14/2017
2 Drugmakers Seek to Block Arkansas from Using Their Drugs to Execute 7 Men 4/14/2017
Nexvet Stock Skyrockets on $85 Million Takeover Offer from Zoetis (ZTS) 4/14/2017
Proxy War Between Bay Area Innovia and Sarissa Heats Up, Could Mother of All Bombs Follow at Next Week’s Board Meeting? 4/14/2017
The Top 3 Best Computer Science Jobs in Biotechnology 4/13/2017
Why These 3 Drugmakers Could Buy Incyte (INCY) 4/13/2017
Massachusetts’ Lyndra Nabs $23 Million as It Plans to Start Clinical Trials This Year 4/13/2017
Why This Bay Area Biotech Stock Grew 415% in the Last Year 4/13/2017
Biotech Startup Vyriad Graduates from Mayo Clinic Incubator to Larger Space 4/13/2017
Look Out, Another Biotech Joins San Diego With $40 Million and Will Take on NASH 4/13/2017
Why Roche (RHHBY) is a Hot Pick for Investors Right Now 4/13/2017
Strike It Rich With These 3 Biotech Stocks That Have Late-Stage Drugs 4/13/2017
Wait For It! Trump Tapped Congressman to Become the Next 'Drug Czar' 4/13/2017
It's Official: Ovid CEO Just Filed for $86 Million IPO 4/13/2017
Nothing's Gonna Stop Neurocrine Biosciences (NBIX) Now: Shares Jumped on FDA Approval of the First and Only Drug to Treat Tardive Dyskinesia for Adults 4/13/2017
It's Not Over Yet: Martin Shkreli Stays Mum on Plans for New Biotech Software Company 4/13/2017
Boston's PureTech Gives Birth to New Biotech and Its Name is Nybo Therapeutics 4/12/2017
4-Person Biotech Pens R&D Deal Worth $1 Billion With Drug Giant Novartis AG (NVS) 4/12/2017
SEC Cracks Down on "Fake Biotech News" 4/12/2017
Look Out Biotech! Google (GOOG)'s Parent Alphabet Sets Sights on Poaching Top Talent From Life Sciences and Healthcare 4/12/2017
Shutdown Looming: Unilife  (UNIS) Files for Chapter 11 4/12/2017
Massachusetts Startup Frequency Therapeutics Nabs $32 Million 4/12/2017
What Happens if Gilead (GILD) Went Bigger Than Incyte (INCY) and Made a Play for This Pharma Giant 4/12/2017
Bay Area Avinger Cuts Workforce by 33% 4/12/2017
FDA Picks Boston's Emulate for its Organ-on-a-Chip Technology 4/12/2017
3 Drug Giants That Boasts the Best Pipelines 4/11/2017
GE Corporation (GE)’s Mission to Close the STEM Gender Gap Starts at Local Middle Schools and High Schools 4/11/2017
Takeda (TKPYY) Splits Off a Range of Businesses to Focus on R&D 4/11/2017
Biohaven Eyes $100 Million IPO to Bankroll Trials of Shelved AstraZeneca PLC (AZN), Bristol-Myers Squibb (BMY) Drugs 4/11/2017
And He's Back! Medivation (MDVN)'s David Hung to Helm Vivek Ramaswamy's Axovant (AXON) 4/11/2017
FDA Finally Allows 23andMe to Sell At-Home DNA Tests for 10 Diseases 4/10/2017
Sanofi Genzyme (SNY) Exec Exits to Become CMO of Flexion (FLXN)—Sanofi (SNY)'s Rumored Buyout Target 4/10/2017
These 3 Big Biotechs Could Have New Blockbuster Drugs Very Soon 4/10/2017
Finally! STADA Arzneimittel (STAGn.DE) Accepts $5.6 Billion Takeover Offer From Bain, Cinven 4/10/2017
Gilead (GILD) Quietly Starts Recruiting Employees for China Expansion 4/10/2017
The Bay Area Pharma Stock Investors Could Buy and Hold for the Next 20 Years 4/10/2017
Valeant (VRX) Plummets After Revealing Jaw-Dropping Payday for Its CEO 4/10/2017
Elizabeth Holmes Now Owes Theranos $25 Million 4/7/2017
FDA Calls Regeneron (REGN)'s Evinacumab a Breakthrough 4/7/2017
Why Ex-Ariad (ARIA) CEO Joining This Biotech's Board Could Mean a Buyout Deal Is Coming 4/7/2017
3 Successful Data Science Students Tell You What It Takes To Become a Data Scientist 4/7/2017
Massive $1.2 Billion Biotech Center in New York Will Create Thousands of New Jobs 4/7/2017
Pharma Giant Merck & Co. (MRK) Considering 600-Job IT Hub in Austin 4/7/2017
One of the Most Controversial Drug Companies in America Is Out of the Industry's Lobby 4/7/2017
Johnson & Johnson (JNJ) Forges Peptide Discovery Pact Worth $1.5 Billion With Japanese Biopharma Peptidream 4/7/2017
Unfavorable Ruling Forces Acorda (ACOR) to Pink Slip 20% of Jobs 4/6/2017
Ex-Gilead (GILD) Director Founded and Will Helm Bay Area Cancer Startup Gilead (GILD) 4/6/2017
On Display Today: President Trump's FDA Nominee Has Ties to These Companies 4/6/2017
Novogen (NVGN) Terminates Preclinical Program, Will Cut an Undisclosed Number of Jobs 4/6/2017
Halozyme (HALO) CEO: PEGPH20 Bolsters Checkpoint Inhibitors in Preclinical Data 4/6/2017
Sexual Harassment Claims Lead Eli Lilly (LLY), Pfizer (PFE), Sanofi (SNY) and More to Pull the Plug on Ads From Bill O'Reilly's Show 4/6/2017
Why Bill Ackman Really Left Valeant (VRX) 4/6/2017
Sanofi Genzyme (SNY) Head to Leave After 23 Years on the Job, Replacement Named 4/6/2017
Pharma Giant Takeda (TKPYY) Turns to Tiny Finch Therapeutics to Develop GI Therapies Based on Bacteria Found in Poop 4/5/2017
Unilife  (UNIS) Slashes Workforce and May Not Have Enough Cash to Survive Beyond This Week 4/5/2017
Astellas (ALPMY) Takes Out Belgium Biotech in Deal Worth $853 Million 4/5/2017
3 Hot to Scorchingly Promising Biotech Stocks 4/5/2017
Aralez Slashing 32% of U.S. Salesforce to Save Some Cash 4/5/2017
Bristol-Myers Squibb (BMY)'s Next Big Bet After Opdivo Failure—IDOs 4/4/2017
Teva (TEVA) Finally Wins FDA Approval for Potential Huntington’s Blockbuster Austedo 4/4/2017
What a Day! Genentech (RHHBY) Lands FDA Approval for First Drug to Treat Severe Multiple Sclerosis 4/4/2017
Before We Act Impulsively on Drug Prices We Should Make Precision Policies 4/4/2017
World's Richest Doctor Allegedly Threatened to Abandon Investment Unless Troubled Media Firm Invested in NantKwest 4/4/2017
Struggling Aviragen (AVIR) Slashes 25% of Workforce, Considers Strategic Options 4/4/2017
This Little-Known $12 Billion SoCal Startup Wants to Cure Baldness and Smooth Out Your Wrinkles 4/4/2017
4 Drug Stocks With Major FDA Decisions Coming This Month 4/4/2017
Sarepta (SRPT) CEO Gives CMO Role to Former Amgen (AMGN)-Regeneron (REGN) Alum 4/4/2017
Bristol-Myers Squibb (BMY) Who? Why Pfizer (PFE) Could be Making Googly Eyes at This Michigan Biotech Instead 4/4/2017
3 Biotechs Wall Street Predicts is Heading Toward Tremendous Growth 4/3/2017
President Trump's Right-Hand Woman, Kellyanne Conway Consulted for Nation’s Leading Science Group 4/3/2017
Novartis AG (NVS) Looks Over Its Shoulder as Kite Pharma (KITE) Hits Its BLA Filing Deadline 4/3/2017
3 Biotechs That Could be Taken Out This Quarter 4/3/2017
2 Biotechs That May Disappear by 2020 4/3/2017
Novartis AG (NVS)'s Talent Woes Continue as Seattle Genetics (SGEN) Poaches a Top CAR-T Exec 4/3/2017
Interview Insider: Tips on How to Get Hired From Merck & Co. (MRK), Eli Lilly (LLY) and Pfizer (PFE) 4/3/2017
Google (GOOG) Backs Another Biotech Startup: This One Wants to Develop a 'Biotech Superglue' to Create New Vaccines 4/3/2017
Former Pfizer (PFE) Neuroscientist to Helm New York Biotech Vencerx 4/3/2017
Sucampo (SCMP) Pays $200 Million Upfront for Rare Disease Biotech Vtesse 4/3/2017
Mass Layoffs Hit Ariad (ARIA) Employees After Takeda (TKPYY)'s $5.2 Billion Buyout Deal 3/31/2017
Novartis AG (NVS) Ordered to Hand Over 80,000 Records of `Sham' Events for Doctors 3/31/2017
Top Pros and Cons of Contract Work in the Life Sciences Industry 3/31/2017
Tango Therapeutics Officially Debuts With $55 Million and a Crew of Superstar Scientific Advisers 3/31/2017
How to Find Hidden Lucrative Life Science Jobs in Government 3/31/2017
The 4 Most Cash-Rich Drugmakers Right Now 3/31/2017
Bay Area's Depomed (DEPO) Craters as New CEO, Directors are Named in Deal With Activist Investor 3/30/2017
Massachusetts' Agenus (AGEN) to Phase Out 20% of Jobs, Shutter Switzerland Facility in Restructuring 3/30/2017
Novartis AG (NVS) Jumps Into the Front of the CAR-T Line With Speedy Review of New Leukemia Drug 3/30/2017
Celgene (CELG) Stocks Up on More Juno (JUNO) Stock After Failed Flagship Drug Trial 3/30/2017
Vertex (VRTX) Consolidating R&D Ops in 3 Locations, Shutters Site in Canada 3/30/2017
Cambridge Biotech Solid Biosciences Rakes in $50 Million Series C to Move DMD Program Forward 3/30/2017
Tiny Massachusetts Phenom Corbus (CRBP) Plunges Despite Reporting Positive Phase II CF Data 3/30/2017
And It Begins...President Trump Looks to Cut $1.2 Billion of NIH R&D Spending This Year 3/30/2017
Trump's FDA Head Nominee to Recuse Himself From Decisions Involving 20+ Companies 3/29/2017
Biogen (BIIB) Loses Gene Therapy Pioneer to REGENXBIO 3/29/2017
Elon Musk Launches Neuroscience Startup to Plug AI Into Your Brain 3/29/2017
FDA Clears Massachusetts Biotech Tesaro (TSRO)'s Ovarian Cancer PARP Inhibitor 3/29/2017
While 3-Way Bids Go On, STADA Arzneimittel (STAGn.DE) CEO's Car is Bugged, Received Photos of Himself in Personal or Private Biz Situations 3/29/2017
Johnson & Johnson (JNJ)'s $100,000 Anti-Burnout Program for Top Execs 3/29/2017
Never Say Never: Why Taking Out Bristol-Myers Squibb (BMY) Could Boost Pfizer (PFE)'s Value by $5 Billion 3/29/2017
Drug Giant Amgen (AMGN) to Create Hundreds of New Jobs in Florida 3/29/2017
Bay Area's CymaBay Therapeutics CEO To Retire, Interim Leader Named 3/29/2017
A Look at Biogen (BIIB)'s Big Bet on the Holy Grail of Science—Alzheimer's 3/29/2017
Former Baxalta (BXLT) CEO to Helm Struggling Alexion (ALXN) 3/28/2017
Nearly 500 Amgen (AMGN) Staffers to be Reassigned, Relocated or Laid Off in Restructuring 3/28/2017
Questions Arise Over the World's Richest Doctor's 'Breakthrough' Cancer Therapy Promo Videos 3/28/2017
Media Mogul Rupert Murdoch Dumps $125 Million Theranos Stake for $1 3/28/2017
These Two Drugmakers Have Even More Debt Than Valeant (VRX) 3/28/2017
GE Healthcare to Invest $500 Million and Hire 5,000 Software Engineers 3/28/2017
NYC Data Science Academy Founder Boots Up New Data Scientists’ Careers 3/28/2017
Filings Reveal Concert Pharma (CNCE) Spurned $250 Million Buyout Offer From Vertex (VRTX) in November 2016 3/27/2017
How This New Jersey Biotech is Taking on Amgen (AMGN) 3/27/2017
This Colorado Pharma May Not Have Enough Cash to Last 2017 3/27/2017
Theranos CEO Gives Up Own Shares to Investors to Avoid Being Sued 3/27/2017
Rumor Alert: Sanofi (SNY) Close to Scooping Up This Massachusetts Biotech in $1 Billion+ Deal 3/27/2017
3 Biotechs the Super-Rich Regret Buying in 2017 (So Far) 3/27/2017
Google (GOOG)'s Mysterious Biotech Calico Forms a Rare Deal With C4 Therapeutics 3/27/2017
Biogen (BIIB)'s Victory Over $4 Billion MS Patent Spat Makes Company an Even More Attractive M&A Target 3/24/2017
Google (GOOG)'s Verily Employees Make Themselves at Home at Onyx (AMGN)'s Former HQ 3/24/2017
Turns Out Editas Medicine (EDIT)'s R&D Deal With Allergan (AGN) Could be Worth $1 Billion 3/24/2017



//-->